Information Library
Results for: High-quality studies - Clinical Pharmacology
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Intarcia and Quintiles Finalize Innovative Alliance
Press Release — December 13, 2011 – To speed development of a potential ground-breaking therapy for Type 2 diabetes – Intarcia Therapeutics, Inc., and Quintiles announced the signing of definitive agreements making Quintiles a financial and strategic partner for the global clinical development of Intarcia’s ITCA 650 (DUROS® continuous subcutaneous delivery of exenatide).
-
Polish Pharmaceutical and Healthcare Sector
Media Coverage — September 9, 2011
To say ‘Sleeping Giant’ about Poland is no longer true claims Wojciech Przybys, VP EMEA and provides a deeper analysis of the polish clinical research -
Population PK/PD - Modeling and Simulation Optimization Tools
Brochure — February 11, 2011
Population pharmacokinetic/ pharmacodynamic (PK/PD) modeling and simulation, available from Quintiles, is now endorsed by the FDA as often being instrumental in drug approval and labeling. -
QUINTILES PARTNERS WITH FOUNDATION TRUST & UNIVERSITY TO IMPROVE PATIENT CARE AND DRIVE EFFICIENCY IN CLINICAL RESEARCH
Press Release — October 26, 2009 - Guy’s and St Thomas’ NHS Foundation Trust and King’s College London sign collaborative agreement with Quintiles.
-
Utility of Adiponectin as a Biomarker Predictive of Glycemic Efficacy
Media Coverage — June 29, 2009
The project pooled blinded data from existing completed clinical trials contributed by Eli Lilly and Company, GlaxoSmithKline, Hoffmann-LaRoche, Inc, and Merck Research Laboratories into a single database hosted by Quintiles Transnational Corporation. -
Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.
Presentation — June 24, 2009
Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) on “The Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.”
Page 1 of 1 (6 results)
